BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$487M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$393M |
| 3 |
Microsoft
MSFT
|
+$380M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$349M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$312M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Salesforce
CRM
|
+$765M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$368M |
| 4 |
Eli Lilly
LLY
|
+$255M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| 1 | Technology | 18.31% |
| 2 | Consumer Discretionary | 8.56% |
| 3 | Healthcare | 8.43% |
| 4 | Financials | 7.4% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RTLR
1726
DELISTED
Rattler Midstream LP Common Units
RTLR
| $209K | ﹤0.01% |
21,550
+1,549
| +8% | +$15K |
|
|
NE
1727
DELISTED
Noble Corporation
NE
| $209K | ﹤0.01% |
650,730
+541,632
| +496% | +$174K |
|
1728
Applied Industrial Technologies
AIT
$9.94B
| $209K | ﹤0.01% |
3,348
-13,137
| -80% | -$820K |
|
|
KRTX
1729
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $209K | ﹤0.01% |
1,874
-1,570
| -46% | -$175K |
|
1730
Medpace
MEDP
$13.8B
| $209K | ﹤0.01% |
2,243
-9,363
| -81% | -$871K |
|
1731
SouthState Bank Corporation
SSB
$10.2B
| $208K | ﹤0.01% |
4,367
-7,476
| -63% | -$356K |
|
1732
Fulton Financial
FULT
$3.54B
| $208K | ﹤0.01% |
19,757
-9,026
| -31% | -$95K |
|
1733
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.5B
| $208K | ﹤0.01% |
7,907
+3,764
| +91% | +$99K |
|
1734
Ingevity
NGVT
$2.12B
| $207K | ﹤0.01% |
3,947
-3,933
| -50% | -$207K |
|
1735
Essential Properties Realty Trust
EPRT
$5.91B
| $207K | ﹤0.01% |
13,981
-34,426
| -71% | -$511K |
|
1736
Crocs
CROX
$4.23B
| $207K | ﹤0.01% |
5,634
-54,654
| -91% | -$2.01M |
|
1737
ABM Industries
ABM
$2.8B
| $207K | ﹤0.01% |
5,700
-22,410
| -80% | -$813K |
|
|
SLCA
1738
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $207K | ﹤0.01% |
57,275
-92,298
| -62% | -$333K |
|
1739
Integer Holdings
ITGR
$3.55B
| $206K | ﹤0.01% |
2,821
-10,932
| -79% | -$799K |
|
1740
Edgewell Personal Care
EPC
$1.01B
| $206K | ﹤0.01% |
6,608
-25,691
| -80% | -$801K |
|
1741
Quaker Houghton
KWR
$2.46B
| $206K | ﹤0.01% |
1,109
-4,411
| -80% | -$819K |
|
|
SPWR
1742
DELISTED
SunPower Corporation Common Stock
SPWR
| $206K | ﹤0.01% |
41,027
-234,398
| -85% | -$1.18M |
|
|
VG
1743
DELISTED
Vonage Holdings Corporation
VG
| $205K | ﹤0.01% |
20,405
-451,837
| -96% | -$4.55M |
|
1744
Ecopetrol
EC
$18.8B
| $205K | ﹤0.01% |
18,426
-2,596
| -12% | -$28.9K |
|
1745
PetMed Express
PETS
$57.8M
| $205K | ﹤0.01% |
5,745
-5,225
| -48% | -$186K |
|
1746
BCE
BCE
$22.5B
| $205K | ﹤0.01% |
4,900
| – | – |
|
1747
GATX Corp
GATX
$6.05B
| $204K | ﹤0.01% |
3,338
-2,556
| -43% | -$156K |
|
1748
California Water Service
CWT
$2.76B
| $203K | ﹤0.01% |
4,250
-55,940
| -93% | -$2.67M |
|
1749
SSR Mining
SSRM
$4.54B
| $201K | ﹤0.01% |
9,437
-9,527
| -50% | -$203K |
|
1750
Karyopharm Therapeutics
KPTI
$55.9M
| $201K | ﹤0.01% |
708
-1,771
| -71% | -$503K |
|